Aromatase inhibitors: Future directions-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Aromatase inhibitors: Future directions

Published:2005-05 Issue:1-5 Volume:95 Page:183-187
ISSN:0960-0760
Container-title:The Journal of Steroid Biochemistry and Molecular Biology
language:en
Short-container-title:The Journal of Steroid Biochemistry and Molecular Biology

Author:

Osborne C. Kent,Schiff Rachel

Publisher

Elsevier BV

Subject

Cell Biology,Clinical Biochemistry,Endocrinology,Molecular Biology,Molecular Medicine,Biochemistry,Endocrinology, Diabetes and Metabolism

Reference30 articles.

1. Selective estrogen receptor modulators: structure, function, and clinical use;Osborne;J. Clin. Oncol.,2000

2. Cross-talk between estrogen receptor and growth factor pathways as a molecular target for overcoming endocrine resistance;Schiff;Clin. Cancer Res.,2004

3. Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer;Shou;J. Natl. Cancer Inst.,2004

4. Inhibition of aromatase as treatment of breast carcinoma in postmenopausal women;Santen;J. Lab. Clin. Med.,1987

5. Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial;Ellis;J. Clin. Oncol.,2001

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and sociodemographic risk factors associated with the development of second primary cancers among postmenopausal breast cancer survivors;Breast Cancer;2022-11-01

2. Aromatase inhibitors: Role in postmenopausal breast cancer;Archiv der Pharmazie;2020-05-25

3. TP53 Mutations and Outcomes in Breast Cancer: Reading beyond the Headlines;Trends in Cancer;2020-02

4. Recent Development in Indole Derivatives as Anticancer Agents for Breast Cancer;Anti-Cancer Agents in Medicinal Chemistry;2019-08-21

5. Aromatase Inhibitors Evolution as Potential Class of Drugs in the Treatment of Postmenopausal Breast Cancer Women;Mini-Reviews in Medicinal Chemistry;2018-03-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3